KHIDI: Running mate for a healthier tomorrow in Korea

Caimi

Caimi Co., Ltd. was established in 2020. The company develops artificial intelli­gence-based digestive cancer and lesion di­agnostic equipment. In August 2023, Caimi completed research and development of medical devices that detect various lesions including malignant tumours through real-time analysis of gastrointestinal endoscopy image data and released an artificial intelli­gence medical device called “ALPHAON.”

Starting with the artificial intelligence medical device “ALPHAON STOMACH” for the upper gastrointestinal tract in 2023, Cami then developed “ALPHAON CO­LON” equipped with colon lesion function in 2024, allowing the detection of lesions in the oesophagus, stomach and colon at the same time. In addition, we are preparing various additional services such as ALPH­AON-T, an educational service, by secur­ing various clinical data.

Caimi’s Alphaon automatically marks the lesion or suspected lesion area in the endoscope view using an AI function and provides the location in real time using Navigation Mode.
These functions can help inexperienced specialists by assisting them to iden­tify lesions on par with those with more than 10 years of experience in endoscopy.

Alphaon is certified as Korean medi­cal device level 1 and 2 for gastrointes­tinal tract and Korean medical device level 2 for colon. We are preparing for US FDA certification and overseas expansion.

Caimi signed an MoU with a hospital in Dubai in October 2023, and signed an MoU with ECO Waller José Guimara Cavaleiri of Chemol in August 2024. Caimi is currently in the process of establishing a Brazilian corporation to enter Brazil and is preparing for ISO 13485 certification review.

Key products
ALPHAON
Technology and features

1. Main video frame interlocked endoscopic image real-time display Image Display of endoscope system linked to alpha when the AI analysis function is activated, real-time display of lesion areas in the endoscope area.
2. Navigation mode Provide real-time screening location The real-time sign of the examination location (check the examination area and prevent omission)
3. Marking of the lesion site Automatic marking of lesion or suspect­ed lesion areas

As a result of AI analysis, it is possible to check the results of multiple placement/ scrolling application at the top of the latest real-time cover analysis results.

Exported to: Brazil

• For more information, visit: http://www.caimi.co.kr